guinea pig |
LD50 |
intraperitoneal |
30mg/kg (30mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 3, Pg. 1663, 1978. |
guinea pig |
LD50 |
subcutaneous |
30mg/kg (30mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 3, Pg. 1663, 1978. |
man |
TDLo |
intramuscular |
12385ug/kg/16 (12.385mg/kg) |
SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" |
Medical Journal of Australia. Vol. 1, Pg. 305, 1947. |
mouse |
LD50 |
oral |
> 2gm/kg (2000mg/kg) |
|
Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 1, 1955. |
mouse |
LDLo |
intravenous |
1gm/kg (1000mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Journal of Pharmacology and Experimental Therapeutics. Vol. 77, Pg. 70, 1943. |
mouse |
LDLo |
subcutaneous |
3200mg/kg (3200mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 77, Pg. 70, 1943. |